APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$4.81
-1.94% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-87.27
Dividend yield
—
52W range
$4 – $189
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-234.60%
ROA
-76.90%
Debt/equity
0.23x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $170000.00 | $-53.34M | -22,296.47% | -31,385.29% | -31,374.71% |
| 2014 | $45.63M | $-51.12M | 64.38% | -112.84% | -112.02% |
| 2015 | $33.60M | $-59.32M | 49.61% | -181.84% | -176.53% |
| 2016 | $36.43M | $-112.42M | 33.63% | -348.42% | -308.54% |
| 2017 | $14.66M | $6.97M | 65.82% | -368.05% | 47.57% |
| 2018 | $23.07M | $-53.69M | 51.39% | -223.98% | -232.75% |
| 2019 | $32.42M | $-44.70M | -6.89% | -126.33% | -137.85% |
| 2020 | $4.31M | $-17.75M | -314.30% | -638.06% | -411.93% |
| 2021 | $12.29M | $-27.31M | 100.00% | -174.10% | -222.20% |
| 2022 | $3.11M | $8.03M | 100.00% | -919.75% | 257.77% |
| 2023 | $0.00 | $-17.41M | — | — | — |
| 2024 | $0.00 | $-24.13M | — | — | — |
| 2025 | $0.00 | $-25.97M | — | — | — |